139 results on '"Schoots, I.G."'
Search Results
2. Preoperative MRI to assess the anatomical location of positive surgical margin at Robot-Assisted Radical Prostatectomy (RARP)
3. Targeted with perilesional biopsy should be considered as the new standard for the diagnosis of clinically significant prostate cancer. A systemic review & meta-analysis
4. The Impact of Omitting Contralateral Systematic Biopsy on the Surgical Planning of Patients with a Unilateral Suspicious Lesion on Pre-operative MRI undergoing Robot-Assisted Radical Prostatectomy for Prostate Cancer
5. Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission
6. Prostate-specific antigen density (PSAD) in post-magnetic resonance imaging (MRI) risk-stratification to avoid biopsies and detection of low-risk prostate cancer: Results of the MR-PROPER study
7. Beyond Gleason Patterns: Radiomics for cribriform growth differentiation
8. The diagnostic value of fibroblast activation protein inhibitor positron emission tomography/computed tomography in genitourinary malignancies – a systematic review
9. Pre-magnetic resonance imaging (MRI) prostate-specific antigen density (PSAD) risk-stratification to avoid MRIs, biopsies and detection of low-risk prostate cancer: Results of the MR-PROPER study
10. Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.
11. Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting
12. Adjuvant use of PLAsmJet device during cytoreductive surgery for advanced-stage ovarian cancer
13. Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer
14. Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy
15. A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging-directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naive Men
16. Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer
17. Is a quantitative analysis of dynamic contrast-enhanced MRI of added value for prostate cancer diagnosis?
18. A prospective multicenter comparison study of a risk-adapted ultrasound-directed and MRI-directed diagnostic pathway in prostate cancer suspected biopsy naïve men
19. Development of a novel nomogram to identify candidates for extended pelvic lymph-node dissection in prostate cancer using MRI and PSMA pet
20. MRI-guided biopsy for prostate cancer diagnosis: Less is more
21. A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging-directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naïve Men
22. O1 - External validation and addition of PSMA-PET to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: An international multicenter study
23. External validation and addition of PSMA-PET to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: An international multicenter study
24. Extended - targeted-plus-regional - MRI-directed biopsy approach in prostate cancer diagnosis – a systematic review and meta-analysis
25. P080 - Beyond Gleason Patterns: Radiomics for cribriform growth differentiation
26. P010 - Prostate-specific antigen density (PSAD) in post-magnetic resonance imaging (MRI) risk-stratification to avoid biopsies and detection of low-risk prostate cancer: Results of the MR-PROPER study
27. O06 - The diagnostic value of fibroblast activation protein inhibitor positron emission tomography/computed tomography in genitourinary malignancies – a systematic review
28. O05 - Pre-magnetic resonance imaging (MRI) prostate-specific antigen density (PSAD) risk-stratification to avoid MRIs, biopsies and detection of low-risk prostate cancer: Results of the MR-PROPER study
29. Predicting early biochemical progression in prostate cancer patients staged with PSMA PET and multiparametric magnetic resonance imaging
30. A 2-arm pseudo-randomized multicenter (MR PROPER) trial: MRI-directed pathway outperforms TRUS-directed pathway in prostate cancer diagnosis following upfront risk stratification
31. Transrectal and transperineal MRI-guided prostate cancer pathways in biopsy-naïve men
32. Evaluation of oncological outcomes and data quality in studies assessing nerve sparing versus non-nerve sparing radical prostatectomy in non-metastatic prostate cancer: A systematic review
33. Prognostic importance of concomitant non-regional lymph node and bone metastases in men with de novo metastatic prostate cancer
34. Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy
35. ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imaging
36. Fast Magnetic Resonance Imaging as a Viable Method for Directing the Prostate Cancer Diagnostic Pathway
37. PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy-Naive Men With Suspected Prostate Cancer: Narrative Review
38. A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis
39. Can Biparametric Prostate Magnetic Resonance Imaging Fulfill its PROMIS?
40. Focus on the Quality of Prostate Multiparametric Magnetic Resonance Imaging: Synopsis of the ESUR/ESUI Recommendations on Quality Assessment and Interpretation of Images and Radiologists' Training
41. Platinum Opinion Counterview: The Evidence Base for the Benefit of Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis is Sound
42. Analysis of Magnetic Resonance Imaging-directed Biopsy Strategies for Changing the Paradigm of Prostate Cancer Diagnosis
43. Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
44. Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.016: Prebiopsy MRI: Through the Looking Glass
45. Equivocal pi-rads three lesions on prostate magnetic resonance imaging: Risk stratification strategies to avoid mri-targeted biopsies
46. Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis
47. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
48. Focus on the Quality of Prostate Multiparametric Magnetic Resonance Imaging: Synopsis of the ESUR/ESUI Recommendations on Quality Assessment and Interpretation of Images and Radiologists’ Training
49. Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI
50. Automated classification of significant prostate cancer on MRI: A systematic review on the performance of machine learning applications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.